WallStreetZenWallStreetZen

NASDAQ: SLNO
Soleno Therapeutics Inc Stock

$42.85-0.35 (-0.81%)
Updated Mar 27, 2024
SLNO Price
$42.85
Fair Value Price
$10.26
Market Cap
$1.39B
52 Week Low
$2.10
52 Week High
$53.82
P/E
-18.16x
P/B
8.83x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$38.99M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.15
Operating Cash Flow
-$25M
Beta
0.56
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

SLNO Overview

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SLNO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SLNO ($42.85) is overvalued by 317.47% relative to our estimate of its Fair Value price of $10.26 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
SLNO ($42.85) is not significantly undervalued (317.47%) relative to our estimate of its Fair Value price of $10.26 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SLNO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SLNO due diligence checks available for Premium users.

Be the first to know about important SLNO news, forecast changes, insider trades & much more!

SLNO News

Valuation

SLNO fair value

Fair Value of SLNO stock based on Discounted Cash Flow (DCF)
Price
$42.85
Fair Value
$10.26
Overvalued by
317.47%
SLNO ($42.85) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SLNO ($42.85) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SLNO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SLNO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-18.16x
Industry
14.3x
Market
44.45x

SLNO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.83x
Industry
6.2x
SLNO is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SLNO's financial health

Profit margin

Revenue
$0.0
Net Income
-$11.3M
Profit Margin
0%
SLNO's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$180.7M
Liabilities
$23.2M
Debt to equity
0.15
SLNO's short-term assets ($171.36M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SLNO's short-term assets ($171.36M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SLNO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SLNO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.3M
Investing
$0.0
Financing
$123.6M
SLNO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SLNO vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
SLNO$1.39B-0.81%-18.16x8.83x
OCUL$1.38B+1.20%-9.22x15.18x
DAWN$1.38B+1.74%-6.66x3.98x
AKRO$1.38B+0.25%-8.46x2.57x
XNCR$1.37B+4.13%-10.78x2.05x

Soleno Therapeutics Stock FAQ

What is Soleno Therapeutics's quote symbol?

(NASDAQ: SLNO) Soleno Therapeutics trades on the NASDAQ under the ticker symbol SLNO. Soleno Therapeutics stock quotes can also be displayed as NASDAQ: SLNO.

If you're new to stock investing, here's how to buy Soleno Therapeutics stock.

What is the 52 week high and low for Soleno Therapeutics (NASDAQ: SLNO)?

(NASDAQ: SLNO) Soleno Therapeutics's 52-week high was $53.82, and its 52-week low was $2.10. It is currently -20.38% from its 52-week high and 1,940.48% from its 52-week low.

How much is Soleno Therapeutics stock worth today?

(NASDAQ: SLNO) Soleno Therapeutics currently has 32,460,579 outstanding shares. With Soleno Therapeutics stock trading at $42.85 per share, the total value of Soleno Therapeutics stock (market capitalization) is $1.39B.

Soleno Therapeutics stock was originally listed at a price of $291.00 in Nov 13, 2014. If you had invested in Soleno Therapeutics stock at $291.00, your return over the last 9 years would have been -85.27%, for an annualized return of -19.17% (not including any dividends or dividend reinvestments).

How much is Soleno Therapeutics's stock price per share?

(NASDAQ: SLNO) Soleno Therapeutics stock price per share is $42.85 today (as of Mar 27, 2024).

What is Soleno Therapeutics's Market Cap?

(NASDAQ: SLNO) Soleno Therapeutics's market cap is $1.39B, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Soleno Therapeutics's market cap is calculated by multiplying SLNO's current stock price of $42.85 by SLNO's total outstanding shares of 32,460,579.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.